AMERICAN SHARED HOSPITAL SERVICES Revenue
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Revenue of $8.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $8.43M, a 19.22% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $7.08M, a 15.90% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $7.73M, a 14.79% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $7.17M, a 2.46% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for fiscal 2025 was $28.08M, a 0.91% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for fiscal 2024 was $28.34M, a 32.90% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for fiscal 2023 was $21.32M, a 8.00% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES revenue from contract with customer, excluding assessed tax for fiscal 2022 was $19.75M, a 12.01% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.43M 10-Q · filed 2026-08-13 | $15.51M 10-Q · filed 2026-08-13 | $23.24M derived: sum of 3 quarters · filed 2026-08-13 | $30.41M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $7.08M 10-Q · filed 2026-05-14 | $14.81M derived: sum of 2 quarters · filed 2026-05-14 | $21.98M derived: sum of 3 quarters · filed 2026-05-14 | $29.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $7.73M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $14.90M derived: sum of 2 quarters · filed 2026-03-31 | $21.97M derived: sum of 3 quarters · filed 2026-08-13 | $28.08M 10-K · filed 2026-03-31 |
| 2025-09-30 | $7.17M 10-Q/A · filed 2026-01-16 | $14.24M derived: sum of 2 quarters · filed 2026-08-13 | $20.35M 10-Q/A · filed 2026-01-16 | $29.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $7.07M 10-Q · filed 2026-08-13 | $13.18M 10-Q · filed 2026-08-13 | $22.25M derived: sum of 3 quarters · filed 2026-08-13 | $29.25M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.11M 10-Q · filed 2026-05-14 | $15.18M derived: sum of 2 quarters · filed 2026-05-14 | $22.18M derived: sum of 3 quarters · filed 2026-05-14 | $29.24M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $9.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $16.07M derived: sum of 2 quarters · filed 2026-03-31 | $23.12M derived: sum of 3 quarters · filed 2026-03-31 | $28.34M 10-K · filed 2026-03-31 |
| 2024-09-30 | $7.00M 10-Q/A · filed 2026-01-16 | $14.05M derived: sum of 2 quarters · filed 2026-01-16 | $19.27M 10-Q/A · filed 2026-01-16 | $24.97M derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | $7.06M 10-Q · filed 2025-08-13 | $12.27M 10-Q · filed 2025-08-13 | $17.97M derived: sum of 3 quarters · filed 2025-08-13 | $23.10M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $5.22M 10-Q · filed 2025-05-15 | $10.91M derived: sum of 2 quarters · filed 2025-05-15 | $16.05M derived: sum of 3 quarters · filed 2025-05-15 | $21.62M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $10.83M derived: sum of 2 quarters · filed 2025-04-04 | $16.40M derived: sum of 3 quarters · filed 2025-04-04 | $21.32M 10-K · filed 2025-04-04 |
| 2023-09-30 | $5.13M 10-Q · filed 2024-11-14 | $10.70M derived: sum of 2 quarters · filed 2024-11-14 | $15.63M 10-Q · filed 2024-11-14 | $20.66M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.57M 10-Q · filed 2024-08-14 | $10.49M 10-Q · filed 2024-08-14 | $15.53M derived: sum of 3 quarters · filed 2024-08-14 | $20.36M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $4.92M 10-Q · filed 2024-05-15 | $9.96M derived: sum of 2 quarters · filed 2024-05-15 | $14.79M derived: sum of 3 quarters · filed 2024-05-15 | $19.82M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $9.87M derived: sum of 2 quarters · filed 2024-04-01 | $14.90M derived: sum of 3 quarters · filed 2024-04-01 | $19.75M 10-K · filed 2024-04-01 |
| 2022-09-30 | $4.83M 10-Q · filed 2023-11-14 | $9.86M derived: sum of 2 quarters · filed 2023-11-14 | $14.71M 10-Q · filed 2023-11-14 | $19.40M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $5.03M 10-Q · filed 2023-08-14 | $9.88M 10-Q · filed 2023-08-14 | $14.57M derived: sum of 3 quarters · filed 2023-08-14 | $18.67M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $4.85M 10-Q · filed 2023-05-12 | $9.54M derived: sum of 2 quarters · filed 2023-05-12 | $13.63M derived: sum of 3 quarters · filed 2023-05-12 | $18.11M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $8.79M derived: sum of 2 quarters · filed 2023-03-31 | $13.26M derived: sum of 3 quarters · filed 2023-03-31 | $17.63M 10-K · filed 2023-03-31 |
| 2021-09-30 | $4.10M 10-Q · filed 2022-11-10 | $8.57M derived: sum of 2 quarters · filed 2022-11-10 | $12.94M 10-Q · filed 2022-11-10 | $17.55M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.48M 10-Q · filed 2022-08-15 | $8.84M 10-Q · filed 2022-08-15 | $13.45M derived: sum of 3 quarters · filed 2022-08-15 | $18.12M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.36M 10-Q · filed 2022-05-12 | $8.97M derived: sum of 2 quarters · filed 2022-05-12 | $13.64M derived: sum of 3 quarters · filed 2022-05-12 | $17.63M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $9.28M derived: sum of 2 quarters · filed 2022-03-30 | $13.27M derived: sum of 3 quarters · filed 2022-03-30 | $17.84M 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.67M 10-Q · filed 2021-11-10 | $8.66M derived: sum of 2 quarters · filed 2021-11-10 | $13.23M 10-Q · filed 2021-11-10 | $18.02M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.99M 10-Q · filed 2021-08-12 | $8.56M 10-Q · filed 2021-08-12 | $13.35M derived: sum of 3 quarters · filed 2021-08-12 | $18.65M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $4.57M 10-Q · filed 2021-05-13 | $9.35M derived: sum of 2 quarters · filed 2021-05-13 | $14.65M derived: sum of 3 quarters · filed 2021-05-13 | $19.85M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06 | $10.09M derived: sum of 2 quarters · filed 2021-04-06 | $15.28M derived: sum of 3 quarters · filed 2021-04-06 | $20.61M 10-K · filed 2021-04-06 |
| 2019-09-30 | $5.30M 10-Q · filed 2020-11-13 | $10.50M derived: sum of 2 quarters · filed 2020-11-13 | $15.82M 10-Q · filed 2020-11-13 | $20.59M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $5.20M 10-Q · filed 2020-08-14 | $10.52M 10-Q · filed 2020-08-14 | $15.29M derived: sum of 3 quarters · filed 2020-08-14 | $19.76M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $5.32M 10-Q/A · filed 2020-06-11 | $10.09M derived: sum of 2 quarters · filed 2020-06-11 | $14.56M derived: sum of 3 quarters · filed 2020-06-11 | $19.73M derived: sum of 4 quarters · filed 2020-06-11 |
| 2018-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $9.24M derived: sum of 2 quarters · filed 2020-04-03 | $14.41M derived: sum of 3 quarters · filed 2020-04-03 | $19.71M 10-K · filed 2020-04-03 |
| 2018-09-30 | $4.47M 10-Q · filed 2019-11-07 | $9.64M derived: sum of 2 quarters · filed 2019-11-07 | $14.94M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $5.17M 10-Q · filed 2019-08-13 | $10.47M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $19.56M 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |